Prevymis (letermovir) - Merck (MSD)
The dual effects of letermovir in allogeneic hematopoietic stem cell transplantation (PubMed, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi) - Jul 17, 2026 - "This review aims to systematically summarize the dual effects of letermovir in allo-HSCT and analyzes its pharmacological mechanisms, clinical efficacy, impact on immune reconstitution, and potential consequences. Furthermore, it explores individualized management strategies based on immune monitoring to provide a theoretical basis for optimizing clinical practice." 
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Graft versus Host Disease • Immunology • Infectious Disease • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42463313
 
Jiaying Gao; Weiwei Qin; Xiaotong Gao; Yueru Ji
 
Jul 17, 2026
 
Prev Next